Continuing to make new medicines affordable for Australians

A new medicine to treat soft tissue sarcoma will be available through the Pharmaceutical Benefits Scheme (PBS) from today, giving more than 100 Australians a year access to affordable life-improving treatment. Eribulin (Halaven®) provides eligible patients with an alternative treatment to currently listed medicines.  It works by inhibiting the growth of cancer cells. The independent…